Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
This webinar delves into the dynamic landscape of COAs, examining their historical use and significance, current uses and best practices, and making a case for greater standardization in their implementation.
Gero Secures $6M in Series A Extension Round to Advance AI-Based Age-Related Disease Research
Biotechnology company Gero has secured $6M in a Series A extension round led by Melnichek Investments. [...]
Key Steps to Enhance Success Rate and Validity in Pharmaceutical Clinical Trials
Bringing a new drug to market takes pharmaceutical companies 10 to 15 years and more than [...]
Obesity Underrepresentation in Clinical Trials Leads to Concerns Over Drug Efficacy and Safety
Obesity is often not represented adequately in drug development trials, causing uncertainties about drug efficacy and [...]
Optimizing Clinical Trials for Greater Payer Acceptance and Enhanced Patient Access
Biopharma manufacturers face challenges in conveying the clinical value of their medicines to payers due to [...]
Groundbreaking BRAIN Initiative Reveals 3,300 Types of Brain Cells, Offering New Leads for Disease Research and Therapies
Scientists have produced an extensive catalog detailing the types of cells in the human brain and [...]
Recent Biopharmaceutical Updates: Workplace Cuts at Sana, NASH Treatment Setbacks, ALS Treatment Appeals, and Alnylam’s Future
Recent updates from the biopharmaceutical world: Sana Biotechnology: The company is laying off approximately one-third of [...]
FDA Denies Alnylam Pharmaceuticals’ Expansion Plans for Onpattro Treatment
The FDA has denied Alnylam Pharmaceuticals' request to expand the use of its siRNA injection Onpattro for the treatment of [...]
Johnson & Johnson’s Drug Combination Improves Progression-Free Survival in Lung Cancer Trial Against AstraZeneca’s Therapy
The Mariposa study showed that a combination of two Johnson & Johnson (J&J) drugs, Rybrevant, and lazertinib, was successful in [...]
Cell & Gene Therapies – Beginning with the End in Mind
This webinar discusses how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after [...]
Class-Action Lawsuit Targets Johnson & Johnson and IBM after Data Breach
Johnson & Johnson and IBM face a proposed class-action lawsuit following a data breach at J&J’s [...]
AstraZeneca and Daiichi Sankyo Plan Approval Filing for Breast Cancer Treatment Following Promising Trial Results
AstraZeneca and Daiichi Sankyo plan to seek approval for their breast cancer treatment datopotamab deruxtecan (Dato-DXd) [...]
Risk of Long Covid Increases with Each COVID-19 Reinfection, Indicates Study
The coronavirus pandemic has prompted questions about reinfection and the risk of developing "long Covid" characterized [...]
Gender-Affirming Care: The Challenges and Ethics of Randomized Controlled Trials
To offer gender-affirming care, such as hormone treatments, clinicians often need to manipulate medical coding systems [...]
Alexion Pharmaceuticals Nears $125M Settlement in Class Action Lawsuit Over Alleged Unethical Sales Practices
A 2016 class action lawsuit against pharmaceutical company Alexion, which claimed that the company's unethical sales [...]
Cognitive Ability Tied to COVID-19 Vaccination Rates
The study published in the Journal of Health Economics investigated a link between an individual's cognitive [...]
FDA Approves Updated Covid-19 Booster Shots from Pfizer/BioNTech and Moderna
The FDA has approved updated Covid-19 booster shots from Pfizer/BioNTech and Moderna for the fall season. The CDC's vaccine advisors [...]
AstraZeneca Inks $42M Deal with Verge Genomics for AI-Driven Drug Discovery in Rare Neurodegenerative Diseases
Verge Genomics, an AI-drug discovery biotech company, has entered into a $42 million deal with AstraZeneca to discover new treatments [...]
Major Transformations Expected in Clinical Trials Industry with Projected Growth to USD 73.2 Billion by 2028
The clinical trials industry is predicted to evolve significantly, with advancements in technology like AI, machine learning, and blockchain that [...]
Seagen and Nurix Partner to Develop New Cancer Therapy, Deal Could Reach $3.4 Billion
Seattle-based biotech Seagen will partner with Nurix to develop degrader-antibody conjugates (DACs), a new type of cancer therapy. Seagen is [...]
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
IPG Health Debuts Diversity Initiative for Clinical Trials
IPG Health announced a new clinical trial diversity offering aimed at ensuring equitable representation across various aspects of diversity, including [...]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish [...]
Act4Biosimilars Advocacy Group Strives to Boost Global Adoption of Biosimilars by 2030
Act4Biosimilars, a global biosimilar advocacy initiative, aims to increase global adoption of biosimilars by at least [...]
